Determining the value of medical technologies to treat ultra-rare disorders: a consensus statement

BACKGROUND: In most jurisdictions, policies have been adopted to encourage the development of treatments for rare or orphan diseases. While successful as assessed against their primary objective, these policies have prompted concerns among payers about the economic burden that might be caused by an...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Mark Access Health Policy
Autori principali: Schlander, Michael, Garattini, Silvio, Kolominsky-Rabas, Peter, Nord, Erik, Persson, Ulf, Postma, Maarten, Richardson, Jeff, Simoens, Steven, de Solà-Morales, Oriol, Tolley, Keith, Toumi, Mondher
Natura: Artigo
Lingua:Inglês
Pubblicazione: Co-Action Publishing 2016
Soggetti:
Original Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5087264/
https://ncbi.nlm.nih.gov/pubmed/27857828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3402/jmahp.v4.33039
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi